Comparison of Transplacental Treatment of Fetal Supraventricular Tachyarrhythmias With Digoxin, Flecainide, and Sotalol: Results of a Nonrandomized Multicenter Study
暂无分享,去创建一个
Greg Ryan | Brian W. McCrindle | B. McCrindle | N. Blom | E. Jaeggi | O. Api | C. Manlhiot | G. Ryan | S. Clur | Nico A. Blom | Cedric Manlhiot | L. Rammeloo | J. Carvalho | Edgar T. Jaeggi | Julene S. Carvalho | Ernestine De Groot | Olus Api | Sally-Ann B. Clur | Lukas Rammeloo | E. D. de Groot
[1] S. Gidding,et al. Fetal tachycardia: mechanisms and predictors of hydrops fetalis. , 1996, Journal of the American College of Cardiology.
[2] J. Younis,et al. Insufficient transplacental digoxin transfer in severe hydrops fetalis. , 1987, American journal of obstetrics and gynecology.
[3] J. Brenner,et al. Atrial flutter in the perinatal age group: diagnosis, management and outcome. , 2000, Journal of the American College of Cardiology.
[4] F. Prefumo,et al. Evaluation of fetal arrhythmias from simultaneous pulsed wave Doppler in pulmonary artery and vein , 2006, Heart.
[5] L. Hornberger,et al. Textbook of Fetal Cardiology , 2000 .
[6] R. Frydman,et al. Flecainide Distribution, Transplacental Passage, and Accumulation in the Amniotic Fluid during the Third Trimester of Pregnancy , 1994, The Annals of pharmacotherapy.
[7] J. Wladimiroff,et al. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia , 1995, Prenatal diagnosis.
[8] L. Shenker. Fetal arrhythmias. , 1987, Journal of the American College of Cardiology.
[9] A. Baschat,et al. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia , 2002, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[10] L. Baxi,et al. Fetal Response Time to Transplacental Digoxin Therapy for Supraventricular Tachyarrhythmia: A Meta-Analysis , 1993 .
[11] O. Uzun,et al. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment , 2011, Cardiology in the Young.
[12] T. Doyle. Textbook of Fetal Cardiology , 2003, Journal of Perinatology.
[13] L. Allan,et al. Flecainide in the treatment of fetal tachycardias. , 1991, British heart journal.
[14] V. Aiello,et al. Perinatal Outcome of Fetal Atrioventricular Block: One-Hundred-Sixteen Cases From a Single Institution , 2008, Circulation.
[15] G. Visser,et al. Sotalol in the treatment of fetal dysrhythmias. , 2000, Circulation.
[16] T. D. Sellers,et al. Digitalis in the Pre-excitation Syndrome: Analysis during Atrial Fibrillation , 1977, Circulation.
[17] J. Simpson,et al. Fetal tachycardias: management and outcome of 127 consecutive cases , 1998, Heart.
[18] E. Villain,et al. Fetal supraventricular tachycardia: a role for amiodarone as second‐line therapy? , 2003, Prenatal diagnosis.
[19] E. Jaeggi,et al. Ventriculo-atrial time interval measured on M mode echocardiography: a determining element in diagnosis, treatment, and prognosis of fetal supraventricular tachycardia , 1998, Heart.
[20] J. Simpson,et al. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia , 2003, Heart.
[21] A. Wear. CIRCULATION , 1964, The Lancet.
[22] B. Cuneo,et al. Amiodarone Therapy for Drug-Refractory Fetal Tachycardia , 2004, Circulation.
[23] E. Jaeggi,et al. Foetal supraventricular tachycardia treated with sotalol , 1998, Acta paediatrica.
[24] Mimi Y. Kim,et al. Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. , 2009, The American journal of cardiology.
[25] J. Hobbins,et al. Treatment of fetal supraventricular tachyarrhythmias , 1985, Journal of clinical ultrasound : JCU.
[26] C. Boutin,et al. Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings , 2003, Heart.
[27] J. Simpson,et al. Outcome of Intermittent Tachyarrhythmias in the Fetus , 1997, Pediatric Cardiology.
[28] N. Blom,et al. Perinatal management and long-term cardiac outcome in fetal arrhythmia. , 2011, Early human development.
[29] U. Gembruch,et al. Fetal tachyarrhythmias: transplacental and direct treatment of the fetus—a report of 60 cases , 1991, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[30] J. Brenner,et al. Management outcome and follow-up of fetal tachycardia. , 1994, Journal of the American College of Cardiology.
[31] G. Visser,et al. Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. , 2003, Journal of the American College of Cardiology.
[32] E. Jaeggi,et al. Fetal atrial flutter: diagnosis, clinical features, treatment, and outcome. , 1998, The Journal of pediatrics.
[33] E. Jaeggi,et al. CHAPTER 12 – Pharmacological and Interventional Fetal Cardiovascular Treatment , 2010 .
[34] U. Chitkara,et al. TRANSPLACENTAL CARDIOVERSION OF INTRAUTERINE SUPRAVENTRICULAR TACHYCARDIA WITH DIGITALIS , 1980, The Lancet.
[35] T. Cordes,et al. Second-Line Treatment of Fetal Supraventricular Tachycardia Using Flecainide Acetate , 2001, Pediatric Cardiology.